According to the Heart and Stroke Foundation of Canada, cardiovascular disease claims more than 69,500 Canadians lives annually, and costs the Canadian economy approximately $20.9 billion in medical services, hospitalization expenses, loss of income and lost productivity. Cardiovascular disease, which includes hypertension (high blood pressure), high cholesterol, thrombosis (blood clotting), heart failure and arrhythmia (abnormal heart rhythms), remains one of the leading causes of illness in the world today.
AstraZeneca has played a major role in the development and advancement of drug therapy for the treatment of cardiovascular disease. As a result, many people with heart disease are living healthier and longer lives. Our portfolio of cardiovascular medications offers doctors safe, effective treatment options that help to reduce the risk, prevalence and impact of cardiovascular disease.